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Abstract
Background: The small molecule 6-bromoindirubin-30-oxime (BIO), a glycogen synthase kinase 3 (GSK3) inhibitor, is a
pharmacological agent known to maintain self-renewal in human and mouse embryonic stem cells (ESCs). However, the
precise role of GSK3 in immortalized pancreatic mesenchymal stem cells (iPMSCs) growth and survival is not completely
understood at present.
Results: To determine whether this molecule is involved in controlling the proliferation of iPMSCs, we examined the effect
of BIO on iPMSCs. We found that the inactivation of GSK3 by BIO can robustly stimulate iPMSCs proliferation and mass
formation as shown by QRT-PCR, western blotting, 5-Bromo-2-deoxyuridine (BrdU) immunostaining assay and tunel assay.
However, we did not find the related roles of BIO on b cell differentiation by immunostaining, QRT-PCR assay, glucose-
stimulated insulin release and C-peptide content analysis.
Conclusions: These results suggest that BIO plays a key role in the regulation of cell mass proliferation and maintenance of
the undifferentiated state of iPMSCs.
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Introduction
Diabetes mellitus has now becoming one of the highest among
chronic metabolic diseases which are heavily threatening people’s
health and can develop major damages to many systems and
organs [1]. These syndromes put heavy burden on patients.
Relative or absolute deficiency of pancreatic b-cell mass resulted in
type I and type II diabetes occurrence [2]. Type I diabetes is a
common endocrine disorder by a marked reduction in the number
of pancreatic b-cells, resulting in substantial morbidity and
mortality. Although daily insulin injections remains the most
effective treatment for insufficient insulin secretion and abnormal-
ly high blood glucose levels from diabetes, it does not fully provide
sufficient control of blood glucose that is exerted by endogenous b-
cells [1], which has provided the impetus for intensive research to
discover better methods of sustaining normoglycaemia. Previous
reports have shown that transplantation of b-cells is an efficient
approach to restore the insulin-secreting system and the precisely
tune the insulin release in response to multiple neural and humoral
signals arising within and beyond the islets of Langerhans [3].
However, the discrepancy between the limited number of donor
islets and the high number of patients who could benefit from such
a treatment reflects the need for renewable sources of high quality
islet b-cells through other new methods [4]. The usage of porcine
islet cells is currently viewed as one of the most promising
alternatives not only due to the plenty supply of porcine islet cells,
but also because porcine and human insulin are highly conserved
and physiological glucose levels in porcine are similar to those in
human [5]. The rationale for xenotransplantation is that the im-
planted porcine islets have the potential to mimic the normal
physiological insulin response in type 1 diabetics, so that near-
normal blood glucose levels are achievable without insulin
administration or with a reduced requirement for it [6–7]. New
islets can also be derived from pancreatic stem cells (PSCs).
However, PSCs are rare and have a finite proliferative lifespan,
culminating in permanent growth arrest, known as replicative
senescence, resulting in the inability to multiply and phenotypic
instability [8]. Immortalized pancreatic mesenchymal stem cells
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shared characteristics of typical bone marrow derived MSCs,
ESCs, PSCs and unlimited potential of growth, possessed mul-
tipotent differentiation capacity and could differentiate into other
functional cell types including neural, cardiomyocytes, even follicle
like and islet-like cells by a specific method, which demonstrated
that these cells may provide resources for regenerative medicine,
tissue engineering and basic research [7]. Previous studies have
found that some small molecules regulate the self-renewal of
stem cells [9–11], which bring new approaches in studying the
mechanisms of stem cells and promote their usage.
Glycogen synthase kinase 3 (GSK3), a serine/threonine kinase
with two highly homologous isoforms, GSK3a and GSK3b,i sa
key regulator of numerous signaling pathways, such as Wnt/b-
catenin, PI3K/Akt and Hedgehog (Hh) [12]. Upon activation of
the canonical Wnt pathway, inhibition of GSK3 results in
dephosphorylation of b-catenin leading to its nuclear accumula-
tion. Studies showed that BIO is the first pharmacological agent,
which is an inhibitor of GSK3, shown to maintain self-renewal in
human and mouse ESCs [12–13]. BIO activates Wnt signaling
and is known to sustain pluripotency of both human and mouse
ESCs by inhibiting GSK3b [9–10]. Whether BIO can regulate the
proliferation and differentiation of iPMSCs is still an issue [14–15].
In this study, we investigated the effects of BIO on iPMSC
and found that the inactivation of GSK3 can robustly stimulate
iPMSCs proliferation and mass formation, as shown by QRT-
PCR, western blotting, 5-Bromo-2-deoxyuridine (BrdU) immuno-
staining assay and tunel assay. However, we did not find the
related roles of BIO on pancreatic b cell differentiation derived
from iPMSCs. These results suggested that GSK3 inhibitor-BIO
plays a key role in the regulation of iPMSCs, cell mass pro-
liferation, and maintenance of the undifferentiated state.
Materials and Methods
Culture of iPMSCs
iPMSCs were obtained from our laboratory [7]. Cells were
subcultured with 0.25% (w/v) trypsin (Invitrogen, Carlsbad, CA,
USA) when reaching 70–80% confluency. The culture medium
(Low glucose-DMEM, Invitrogen), containing 15% FBS, 0.1 mM
b-mercaptoethanol (Sigma), 2 mM glutamine (Invitrogen) and
100 mg/mL penicillin/streptomycin, was refreshed every 2–3 days
[6]. BIO (Merck, Padge Road, Beeston Nottingham, NG9 2JR,
UK) was added in culture medium to evaluate its effects on iPMSCs
proliferation. Additionally, 25 ng/mL Wnt3a (R&D Systems, Inc.
614 McKinley Place NE Minneapolis, MN 55413), 50 ng/mL
Dkk1(R&D Systems) alone or in combination with 1 mMB I O ,a n d
LiCl(1,5,10,25and 50 mM,R&DSystems)wereadded inmedium
to evaluate its effects on the proliferation of iPMSCs [16].
In vitro proliferation assay of iPMSCs
iPMSCs were cultured in vitro in the presence (0.1, 0.5, 1.0, 1.5,
2.0 mM) or absence of BIO (Control, the same volume of DMSO
as BIO group) in medium for 3 and 7 days and the number of cells
were counted. The effects of BIO were based on the morphology
and the number of colonies stained with Giemsa. The experiments
were repeated for at least 3 times.
Growth curve
iPMSCs in the presence (1.0 mM) or absence of BIO were
seeded to 24-well plates at a density of 2610
4 cells/well. The
proliferation ability was assessed by growth curve at an interval
of 24 h. The cells were trypsinized and the cell number was
determined for seven consecutive days (n=3). Cell population
doubling time (PDT) was calculated from the formula: PDT=
[log2/(logNt2logN0)]6t, where Nt=the number of cells after t
hours of culturing and N0=number of cells seeded.
Immunofluorescence
In the absence or presence of BIO (1.0 mM, 3 d), cells were fixed
with 4% paraformaldehyde (PFA) for 10 min at room temperature.
Cells were permeabilized with 0.1% Triton X-100 for 10 min,
blocked with 10% goat serum in PBS at room temperature for 1 h,
and incubated with the primary antibodies overnight at 4uC. The
primary antibodies included PDX1 (1:200, Abcam, Cambridge,
MA,USA), Glut2 (1:200, Millipore, Billenca, MA, CA, USA), C-
Myc (1:200, Chemicon, Temecula, CA, USA), PCNA (1:200,
Millipore),TERT (1:200,Chemicon),b-catenin(1:100,SantaCruz,
CA. U.S.A.), C-peptide (1:200, Abcam), Insulin (1:200, Chemicon)
and E-cadherin (1:100, Millipore). After three washes with PBS, the
cells were incubated with the secondary antibodies at room
temperature for 1 h, followed by three washes in the same buffer.
They were then incubated with Hoechst33342(Sigma) or PI (Sigma)
at roomtemperature for 5 min. Images were captured and analysed
with a Leica fluorescent microscope. The percentage of PDX1,
Glut2, C-Myc, PCNA, TERT and b-catenin positive staining in the
absence or presence of BIO was made by manual counting under
fluorescent microscope [17].
RT-PCR
Total RNAs for RT-PCR analysis were extracted from iPMSCs
cultured in the absence or presence of BIO (1.0 mM, 3 d), and
induced iPMSCs using Trizol (Invitrogen). The cDNAs were
synthesized based on 500 ng of RNA with a commercially
available kit (TaKaRa, Biotech. Co. Ltd.). The PCR conditions
included denaturation at 94uC for 5 min, followed by 30 repeated
cycles of 95uC for 30 sec, 55uC–58uC for 30 sec and 72uC for 30–
60 sec, and extension at 72uC for 10 min. The primers were
designed based on the sequences of the open reading frame from
the NCBI GenBank and synthesized by AuGCT Biotechnology
(Beijing). The PCR primers and the length of the amplified
products are shown in Table 1.
The PCR products were analysed in 2% agarose (Invitrogen) gel
electrophoresis, stained with ethidium bromide (Invitrogen), and
visualized under UV illumination.
QRT-PCR
The QRT-PCR reactions were set up in 25 mL reaction mixtures
containing 12.5 mL1 6 SYBR@ PremixExTaqTM (TaKaRa,
Biotech. Co. Ltd.), 0.5 mL sense primer, 0.5 mL antisense primer,
11 mL distilled water, and 0.5 mL template. The reaction conditions
were as follows: 95uC for 30 sec, followed by 40 cycles of 95uC for
5 sec, and 58uC for 20 sec. All expression levels were normalized to
b-actin in each well. Expression was quantified as the ratio of the
mRNA levels obtained from iPMSCs in the absence or presence of
BIO (1.0 mM, 3 d).
Western Blotting
Total cell extracts were prepared from iPMSCs in the absence
or presence of BIO (1.0 mM, 3 d) and fetal porcine pancreas, and
proteins were extracted in 16SDS-PAGE sample loading buffer.
Total cell proteins were resolved by SDS-PAGE, transferred to
PVDF membrane, and probed with b-actin (1:1000, Beyotime,
Haimen, Jiangsu, China), PDX1 (1:1000, Abcam), C-Myc (1:1000,
Chemicon), PCNA (1:1000, Millipore), TERT (1:1000, Chemi-
con), b-catenin (1:100, Santa Cruz), E-cadherin (1:1000, Milli-
pore), P-b-catenin (S33/S37/T41, 1:1000, Bioworld). Horse-
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used as a secondary antibody (1:1000, Beyotime). The detection
was performed using the BM-Chemiluminescence blotting sub-
strate (Roche, Shanghai, China).
BrdU incorporation assay
The proliferation of iPMSCs was assayed by BrdU incorpora-
tion, performed similarly to previous reports [18], but with some
modifications. First, iPMSCs in the absence or presence of BIO
(1.0 mM, 3 d) were treated with 30 mg/mL BrdU (Sigma, St Louis,
MO, USA) for 6 h and then subjected to BrdU immunostaining.
More specifically, cells were fixed in 4% PFA for 15 min at room
temperature and washed three times, for 10 min each with PBS
(pH 7.4) containing 0.1% Triton X-100. The cells were then
washed for three times in PBS (pH 7.4) alone. Anti-BrdU (1:100;
Santa Cruz) dissolved in 0.1 M PBS (pH 7.4) containing 5%
normal goat serum was added and the cells were incubated
overnight at 4uC. Cells were washed in PBS (pH 7.4) three times,
and then incubated with the secondary antibody (FITC, Millipore
1:500) for 1 h at room temperature. Three more washes were
carried out and cells were visualized under a Leica fluorescent
microscope and analysed for BrdU uptake. The rate of BrdU
positive in the absence or presence of BIO was made by manual
counting under fluorescent microscope [17].
Luciferase assays
FOP-Flash plasmids (contain mutated Tcf binding sites), as a
negative control, and TOP-Flash (contain functional Tcf binding
sites) were transiently transfected into iPMSCs in the absence or
presence of BIO (1.0 mM, 3 d) using Lipofectamin-2000 (Invitro-
gen) according to the manufacturer’s instructions. Transfection
was performed in OPTI-MEM (Invitrogen). After 6 h, OPTI-
MEM was replaced by medium with or without BIO. Luciferase
activity was measured using Luciferase Assay System (Promega,
Madison, WI 53711 USA) according to the manufacturer’s
instructions (a luminometer TD-20, Turner Design), TOP-Flash
activity was normalized against FOP-Flash activity.
Tunel assay
Cells cultured with and without BIO were fixed with 4% PFA
for 30 min at room temperature, washed twice with PBS and were
permeated with 0.1% Triton X-100 for 10 min. The cells were
then washed with PBS incubated with tunel reaction mix
(Beyotime) for 60 min in the dark, and were analysed with a
Leica fluorescent microscope. The rate of tunel positive in the
absence or presence of BIO was made by manual counting under
fluorescent microscope [17].
Generation of islet-like clusters derived from iPMSCs
We used a two-step protocol to obtain islet-like cells. First,
iPMSCs were dissociated with 0.05% trypsin at 37uC for 5 min
and cultured in RPMI 1640/B27 medium with or without BIO
(1.0 mM) supplemented with 1% BSA, 100 mM nicotinamide
(NIC, Sigma), 10 ng/mL exendin-4 (Sigma), 1 mM sodium
pyruvate (Invitrogen), 2 mM glutamine (Invitrogen), 1 mM b-
mercaptoethanol (Sigma), 100 mg/mL penicillin/streptomycin,
20 ng/mL EGF (Millipore) and 20 ng/mL bFGF (Millipore) for 7
days. Cells were then cultured for another 7 days in the same
medium supplemented with 10
26 M RA (Sigma) but without EGF
and bFGF. The cells were transferred into ultra-low attachment
plates and cultured in the same medium for 2 weeks. The medium
was changed every 3 days.
The clusters were also identified by immunofluorescent assay
with PDX1, C-peptide and Insulin antibodies. PDX1, Ngn3,
Mafa, Glut2, PC1/3 and Insulin were analysed by QRT-PCR at
day 14 after induction. Uninduced iPMSCs were used as negative
control.
Glucose-stimulated insulin release and insulin content
analysis
After 14 day induction, iPMSC-derived islet clusters were plated
onto 6-well plate in triplicate, approximately 200 clusters/well,
and cultured overnight to ensure the clusters attached to the plate
[7]. Then, the clusters were washed three times with glucose-free
RPMI 1640 medium and the clusters were further incubated with
RPMI 1640 medium containing 25 mM and 5.6 mM glucose at
37uC for another 2 h [19]. In this experiment, the different stages
of clusters subsequently were incubated with 5.6 and 25 mM
glucose for 2 h to determine glucose-stimulated insulin content
and C-peptide release. The RPMI 1640 induction medium was
determined as the basal level of insulin content and C-peptide
release. The supernatant of both low- and high-glucose-treated
Table 1. The PCR primers and the length of the amplified products.
Primers Forward Reverse Product Size(bp) Tm
b-actin 59-gcggcatccacgaaactac-39 59-tgatctccttctgcatcctgtc-39 138 58uC
Pdx1 59-gagcccgaggagaacaagc-39 59-tgacagccagctccaccc-39 121 58uC
Ngn3 59-gcgagttggcactgagca-39 59-aagctgtggtccgctatgc-39 220 58uC
Mafa 59-ttcagcaaggaggaggtcat-39 59-acaggtcccgctctttgg-39 190 58uC
hTERT 59-gtgtgctgcagctcccatttc-39 59-gctgcgtctgggctgtcc-39 264 58uC
PCNA 59-agtggagaacttggaaatggaa-39 59-gagacagtggagtggcttttgt-39 154 58uC
C-Myc 59-ctggtgggcgagatcatca-39 59-cactgccatgaatgatgttcc-39 304 54uC
CyclinA 59-tggctgtgaactacattga-39 59-acaaactctgctacttctgg-39 136 50uC
CyclinD1 59-tgaactacctggaccgct-39 59-caggttccacttgagyttgt-39 212 50uC
CDK2 59-gccaggagttacttctatgc-39 59-tggaagaaagggtgagcc-39 180 53uC
Caspase3 59-gaagaccatagcaaaaggag-39 59-tgtctcaataccacagtcca-39 207 50uC
Glut2 59-ttgccttggatgagttatgtga-39 59-gcgtggtccttgactgaaaa-39 120 bp 58uC
Insulin 59-aagcgtggcatcgtggag-39 59-tcaggactttattgggttttgg-39 128 58uC
doi:10.1371/journal.pone.0031502.t001
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concentrations of glucose were collected and stored at 270uC for
the further analysis. The insulin secretion and content derived the
clusters was performed by RIA [18].
Statistical analysis
The effects of BIO on the proliferation and apoptosis of iPMSCs
were evaluated based on fluorescence staining, QRT-PCR, BrdU
staining and tunel staining. The Data are presented as mean6
SEM and the standard errors of the mean (SEM) in this study
were calculated for 3 replicates in each of the 3 independent
experiments [17]. Statistical comparisons were assessed with
analysis of Student’s test. P,0.05 was considered statistically
significant difference and P,0.01 was considered highly signifi-
cant difference.
Results
The GSK-3 inhibitor BIO promotes self-renewal of iPMSCs
iPMSCs presented as the typical triangles and long spindle cell
morphology of mesenchymal-like cells in the presence and absence
of BIO (Figure 1A). Different concentrations of BIO (0, 0.1, 0.5,
1.0, 1.5, 2.0 mM) were added to the culture medium to evaluate
their effects based on the morphology of iPMSCs colonies stained
with Giemsa. Cell colonies were significantly denser and bigger in
BIO than without BIO (Figure 1B). iPMSCs cultured in the
presence of BIO (0.1, 0.5, 1.0, 1.5, 2.0 mM) for 3 and 7 days in vitro
proliferated faster than that in the absence of BIO (Figure 1C).
The number of cells in the presence of BIO (1.0, 1.5 mM) was
elevated 1.2–2 fold compared with that in the absence of BIO. But
when treated with 2.0 mM BIO, the number of iPMSCs decreased.
In addition, the number of colonies was significantly increased
(about 2 fold, P,0.01) in the presence of BIO (Figure 1D). The
results showed that BIO could promote the proliferation of
iPMSCs, and we concluded that the optimal concentrations were
1.0 and 1.5 mM. Then we detected specific pancreatic stem cell
markers at the mRNA level. Expression of PDX1, Ngn3, PCNA
and C-Myc showed an upward trend in iPMSCs treated with 1.0
and 1.5 mM BIO (Figure 1E) as compared with the control group.
And the expression of C-Myc was clearly increased in the presence
of 1.0 mM BIO compared with 1.5 mM and control. Thus, we used
1.0 mM BIO in the following experiments.
The growth curves of iPMSCs cultured in the absence and
presence of BIO (1.0 mM) were shown in Figure 1F. The cells
Figure 1. Morphology of iPMSCs in the absence or presence of BIO. A-Control, The typical spindle fibroblast-like morphology of iPMSCs; A-
BIO, The morphology of iPMSCs treated with BIO; B, iPMSCs stained with Giemsa in the absence or presence of BIO; C, The number of cells cultured in
the absence or presence of BIO (0.1, 0.5, 1.0, 1.5, 2.0 mM); D, The number of iPMSCs colonies; E, Expression of PDX1, PCNA, Ngn3, TERT and C-Myc
were analysed at mRNA level in the absence and presence of 1.0 and 1.5 mM BIO; F, The growth curves of iPMSCs cultured in the absence and
presence of BIO (1 mM). Bar=20 mm. * P,0.05, **, P,0.01.
doi:10.1371/journal.pone.0031502.g001
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(exponential) phase (Figure 1F). The PDT of iPMSCs cultured in
the absence and presence of BIO (1.0 mM) were 21.97 h VS
19.93 h (P,0.01) , respectively. These results showed that iPMSCs
had a stronger proliferative capacity in the presence of BIO
compared with that in the absence confirmed by growth curves
(Figure 1F).
The iPMSCs also expressed the characteristic surface markers
of PSCs including PDX1 and Glut2 as well as the proliferative
markers of TERT, C-Myc and PCNA (Figure 2A Control) as
shown by immunofluorescence. When cells were seeded at a lower
density, the iPMSCs in the presence of BIO were easier to form
cell mass and expressed PDX1, Glut2, TERT, C-Myc and PCNA
as shown by immunofluorescence staining (Figure 2A). The
percentage of positive cells had an up-trend compared with that
in the absence of BIO: PDX1, 89% VS 60%; Glut2, 80% VS 65%;
PCNA, 70.8% VS 56.2%; C-Myc, 65% VS 37.5% (P,0.05,
respectively), and the TERT-positive cells of iPMSCs in the
presence of BIO were similar to that in the absence of BIO
(P.0.05). The expression levels of the pancreatic stem cell specific
marker PDX1, the proliferative markers C-Myc and PCNA were
up-regulated in BIO medium compared with in the absence of
BIO analysed by QRT-PCR (Figure 2C, P,0.01). Treated with
BIO for 72 h, the expression of PDX1, C-Myc and PCNA were
the highest, with the expression of PDX1 and C-Myc increasing
about 2 fold. The expression of PDX1, PCNA, C-Myc and TERT
protein also had an upward trend compared with untreated cells
by western blotting (Figure 2D). We also found Wnt3a promoted
the proliferation of iPMSCs (P,0.05) and increased the expression
of PCNA, C-Myc and PDX1. However, Dkk1 inhibited the
proliferation of iPMSCs (P,0.05) and the expression of C-Myc
and PDX1 (Figure S1). The expression of cell cycle proteins:
CyclinA and CyclinD were increased in BIO treated cells (Figure
S2). Wnt3a and Dkk1 effect on the proliferation of iPMSCs were
investigated, and we found Wnt3a play a role in mediating the
effects of BIO and Dkk-1 inhibit the effects of BIO (P,0.05)
(Figure S3). LiCl (5 and 10 mM) also stimulated the proliferation of
iPMSCs, however, 25 and 50 mM LiCl inhibited their prolifera-
tion (P,0.05) and the expression of PDX1, C-Myc and PCNA
(P,0.05) (Figure S4).
BrdU incorporation assay demonstrated that the mitosis index
in the presence of BIO was significantly higher than without BIO
(Figure 3A, P,0.05). Control cells had a lower rate of BrdU
incorporation (31.761.3%). In contrast, stimulation of iPMSCs
with 1 mM BIO increased the BrdU incorporation rate to 52.76
1.9% (Figure 3B). These results demonstrated that BIO enhanced
the proliferation of iPMSCs.
Meanwhile, b-catenin was activated when iPMSCs were
cultured in the presence of BIO (Figure 3C). In control cells, b-
catenin staining was weak and appeared to be located at the
cell membrane. In contrast, BIO-stimulated cells showed nuclear
staining, suggesting that there was an increased level of b-catenin
Figure 2. The GSK-3 inhibitor BIO promotes self-renewal of iPMSCs. A, Immunofluorescene staining analysis showed iPMSCs were positive
for PDX1, Glut2, PCNA, C-Myc and TERT in the absence or presence of BIO, Bar=20 mm; B, The percentage of positive cells treated with BIO or not
from A; C, QRT-PCR analysis showed that the expression of pancreatic islets-specific marker PDX1 and pluripotent markers C-Myc, PCNA and TERT had
an up-regulated trend in BIO cultured cells (24, 48, 72 h); D, Treated with BIO (24, 48, 72 h), western blotting analysis showed the expression of PDX1,
PCNA, C-Myc, TERT and E-cadherin proteins had an upward trend compared with untreated cells. Bar=20 mm, * P,0.05, **P,0.01.
doi:10.1371/journal.pone.0031502.g002
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PLoS ONE | www.plosone.org 5 February 2012 | Volume 7 | Issue 2 | e31502Figure 3. b-catenin and BrdU incorporation assay. A, The mitiosis index with BIO was significantly higher than without BIO medium; B, The
percentage of positive cells treated with BIO or not from A; C, BIO treatment caused nuclear accumulation of b-catenin, which was not observed in
control cells; D, Cells were assayed for b-catenin-mediated transcriptional activation by using a reporter containing either functional (TOP-Flash) or
mutated (FOP-Flash) Tcf binding sites. Cells stimulated with BIO showed rise in the levels of b-catenin activity, as measured by luciferase activity.
Treatment with BIO resulted in the higher fold change (almost 4 fold) when TOP-Flash activity was normalized against FOP-Flash activity. There was
no significant difference in activities in the presence of the mutated FOP-Flash reporter; C, Bar=20 mm, *P,0.05; E, Western blotting showed that p-
b-catenin (S33/37/T41) was decreased in BIO treated.
doi:10.1371/journal.pone.0031502.g003
Figure 4. E-cadherin staining analysis. E-cadherin showed a bright membrane staining in untreated (Control) and translocated into cytoplasm in
BIO-treated iPMSCs. Bar=20 mm.
doi:10.1371/journal.pone.0031502.g004
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protein was increased in the presence of BIO, as shown by western
blotting (Figure 2D). The b-catenin/Tcf activity driven from the
TOP-Flash luciferase reporter containing functional Tcf-binding
sites transfected into iPMSCs was enhanced after 3 days in 1.0 mM
BIO treatment, and no activation occurred upon transfection with
FOP-Flash reporter containing mutated Tcf-binding sites. Treat-
ment with 1.0 mM BIO resulted in a higher fold change (almost 4
fold, P,0.01) when TOP-Flash activity was normalized against
FOP-Flash activity (Figure 3D). There was no significant dif-
ference in activities in the presence of the FOP-Flash reporter.
Western blotiing showed that the level of P-b-catenin (S33/S37/
T41) was decreased in BIO treated (Figure 3E).
After treatment with 1.0 mM BIO, iPMSCs were more compact
morphology and aggregated, suggesting a change in cell adhesive-
ness[20].So we studied the intracellularlocalization and the level of
E-cadherin upon BIO stimulation. As visualized by immunofluo-
rescence, E-cadherin showed a bright membrane staining in
untreated iPMSCs, and the expression of E-cadherin protein was
present cytoplasm staining in BIO-treated IPMSCs (Figure 4).
Nearly no or little tunel positive cells were observed in BIO-
supplemented medium. However, some tunel positive cells were
observed (about 3.5%) in the absence of BIO (Figure 5, P,0.01).
Differentiation potential of islets
BIO stimulated iPMSCs to form smaller, denser and more
compact colonies (Figure 1). Further, we investigated the islet
potential differentiation of iPMSCs in the absence or presence
of BIO by inducing the cells with a two-step protocol [7]. On the
14
th day, induced pancreatic islet-like clusters were formed. Islet-
like formation derived from iPMSCs in containing BIO induced
medium were denser (Figure 6). After two weeks, the induced
clusters were transferred into plates and stained positive for PDX1,
C-peptide and Insulin, as analysed by immunofluorescent staining
(Figure 6A). These results provide evidences that the cells in the
induction medium with or without BIO have the potential to
differentiate into islet cell clusters and endocrine cell types in
this protocol [21], and the number of islet cell clusters derived
from iPMSCs were slightly increased in BIO induced medium.
At the mRNA level, we detected endocrine pancreatic islet
markers including PDX1, Ngn3, Mafa, Glut2, PC1/3 and Insulin
expressed in iPMSCs treated with or without BIO, however, BIO
treatment did not alter the expression levels of PDX1, Ngn3,
Mafa, Glut2, PC1/3 and Insulin analysed by QRT-PCR
(Figure 6B).
To determine whether the clusters derived iPMSCs in the
presence or absence of BIO are capable of secretion insulin in
response to glucose stimulation, we tested the ability of iPMSC-
derived islet clusters for C-peptide production after sequential
treatment with low and high concentrations of glucose in a static
assay. The insulin content and C-peptide release levels in 25 mM
and 5.6 mM glucose stimulated group for islets induced derived
from iPMSCs in the presence and absence of BIO were sig-
nificantly higher than that in control cells (P,0.01), and there
were significantly different levels of the secreted insulin and C-
peptide between 25 mM and 5.6 mM glucose stimulated respec-
Figure 5. Tunel staining analysis iPMSCs cultured with BIO or not. Bar=20 mm, **P,0.01.
doi:10.1371/journal.pone.0031502.g005
BIO Regulates iPMSCs
PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e31502tively (P,0.05), however, there weren’t significantly differences
between in the presence and in absence of BIO (Figure 6C,
P.0.05). This suggests that the GSK3 inhibitor- BIO can
maintain the cells in an undifferentiated state, but not affect the
potentiality of differentiation into pancreatic islet.
Discussion
In this study, our results demonstrated that these iPMSCs
proliferated better in the presence of BIO. We found that the
pluripotent iPMSCs could be successfully cultured in BIO medium
and BIO up-regulated the expression of proliferation markers
including C-Myc, TERT and PCNA compared with control.
Moreover, several cell cycle regulators, known to regulate the cell
cycle progression during the G1/S transition, were also detected.
Both Cyclin D1 and Cyclin A were up-regulated by BIO, which
indicated that both of them were involved in regulating cell cycle
progression from G1 to S phase induced by BIO. Simultaneously,
these cells maintained an expression of PSC markers similar to the
control group [7]. Myc is activated through various mitogenic
signals such as Wnt, Shh and EGF (via the MAPK/ERK
pathway). Myc activation results in numerous biological effects
including driving cell proliferation (by up-regulating cyclins),
regulating cell growth (by up-regulating ribosomal RNA and
proteins), apoptosis, differentiation and self-renewal of stem cells.
Myc is a very strong proto-oncogene and its over-expression
stimulates gene amplification [22]. Proliferating cell nuclear
antigen (PCNA) is a distinct marker for the proliferative cell
[23–24], which was up-regulated in BIO medium. These results
demonstrated that BIO may regulate C-Myc, which results in
the up-regulation of PCNA, CDK2, CyclinA and CyclinD1 to
maintain the self-renewal of iPMSCs. Our results have demon-
strated that Wnt3a function in mediating the effects of BIO, while
Dkk-1 inhibit the effects of BIO. However, LiCl has different effect
on iPMSC proliferation at different concentration. GSK3b is the
best-studied target of Li [25]. LiCl promotes the reprogramming
process and the generation of induced pluripotent stem cells
(iPSCs). The results showed that the greatest effect of LiCl was
10 mM. Prolonged treatment of LiCL resulted in the reduction in
the colony size and eventual reduction in the number of colonies of
iPSCs because of a cytotoxic effect [25]. Different concentration of
Li affect the potential of differentiation and proliferation of stem
cells [26–27]. Whether the true mechanism of BIO in iPMSCs is
similar to that in pluripotent stem cells or not, we need to further
study the PI3K/Akt and the MEK/ERK pathway, epigenetics
and the reprogramming mechanisms. The expression of PDX1
and C-Myc protein was increased by GSK3 inhibitor-BIO
analysed by western blotting, which was consistent with previous
studies [28–30]. However, sometime contradictory effects of
GSK3 via the phosphorylation of some proteins were complex.
Figure 6. Potential differentiation of islet cells. A, The induced clusters treated with BIO or not were transferred into plates and stained positive
for PDX1, C-peptide and insulin analysed by immunofluorescent staining; B, The specific markers of pancreatic islets including PDX1, Ngn3, Mafa,
Glut2, PC1/3 and Insulin expressed in the iPMSCs treated with BIO or not by QRT-PCR; C, Glucose-stimulated insulin release and insulin content
analysis. Bar=20 mm, **P,0.01.
doi:10.1371/journal.pone.0031502.g006
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controlled by GSK-3-dependent phosphorylation and that phos-
phorylation by GSK-3 can increase the oncogenic activity of a
protein [31].
Maintenance of self-renewal potential is currently a challenge
for in vitro culture of PSCs because these tissue stem cells isolated
from the in vivo niche rapidly undergo apoptosis in culture if they
lose their suitable microenvironment. Some growth factors and
small molecules are known to be essential for the self-renewal of
pluripotent stem cells [15]. Wnt consists of a large family of secreted
glycoproteins and extracellular Wnt-ligands, which interact with
receptors of the frizzled family, involved in cell proliferation,
differentiation, organogenesis, and cell migration [32–33]. The
function of GSK3 inhibitor-BIO in the culture of pluripotent stem
cells has been previously described [9–10]. Studies have also
demonstrated that BIO stimulated the proliferation of b cells and
cardiomyocytes in vitro [2,17]. Engagement of Wnt ligands withthe
receptor activates the Dishelved (Dsh) protein. Dsh inhibits GSK-3
which leads to Wnt signaling phosphorylating and targeting the b-
catenin-Adenomatous Polyposis Coli (APC) complex for ubiquiti-
nation and proteolytic degradation [12]. Upon Wnt signaling, b-
catenin is stabilized, accumulates in the cytoplasm and is eventually
translocated to the nucleus, where it interacts with DNA-binding
proteins of the T-cell Factor/Lymphocyte Enhancer binding Factor
(Tcf/Lef) family. In the presence of b-catenin, Tcf/Lef act as
transcriptional activity [31]. However, BIO may inhibit GSK3b
activity, and activate Wnt/b-catenin signaling and Ca
2+ signaling
pathways [34–35]. In this study, b-catenin and E-cadherin were
translocated into the nucleus or cytoplasm, and the total b-catenin
was increased in BIO treated. The accumulation of b-catenin is a
clear hallmark of Wnt signaling [36]. Meanwhile, p-b-catenin (S33/
37/T41) was decreased in BIO treated analysed by Western
blotting. These results clearly demonstrated that BIO inhibited
GSK3b activity, and activate Wnt/b-catenin signaling and Ca
2+
signaling pathways in iPMSCs [20]. The key downstream trans-
criptional regulators of the Wnt pathway influence transcription of
target genes including C-Myc, TERT and CDK2, thus, promoting
the proliferation of iPMSCs. Our results first demonstrated that
BIO enhances the proliferation of iPMSCs, activates b-catenin
signaling, and increases the proliferative markers including TERT,
C-Myc and PCNA, as shown by cell morphology, mRNA and
protein levels while it suppresses apoptosis, as shown by tunel
staining and BrdU assay. Meanwhile, the cultured iPMSCs in BIO
maintained the characteristics of iPMSCs. These results were
consistent with previous studies, which have shown that BIO
promote the proliferation of iPMSCs through regulation of the
target genes of b-catenin signaling in b cells and cardiomyocytes
[2,9,15,17,28–30]. Furthermore, our research found that iPMSCs
maintained the undifferentiated state in BIO medium, but did not
change their potentiality to differentiate into insulin producing cells.
Therefore, we report for the first time that BIO may stimulate
iPMSCs self-renewal in vitro. However, we need to elucidate the
molecular mechanisms.
Supporting Information
Figure S1 Wnt3a and Dkk1 effect on the proliferation of
iPMSCs. A, The number of cells treated by 25 ng/mL Wnt3a,
50 ng/mL Dkk1 alone (P,0.05); B, Expression of PDX1, C-Myc,
PCNA and TERT were analysed at mRNA level treated by
25 ng/mL Wnt3a, 50 ng/mL Dkk1 alone; C, Expression of
PDX1, C-Myc, PCNA and TERT were analysed at protein level
treated by 25 ng/mL Wnt3a, 50 ng/mL Dkk1 alone.
(TIF)
Figure S2 RT-PCR analysis the effects of BIO on the
expression of cell cycle proteins in iPMSCs.
(TIF)
Figure S3 The number of iPMSCs treated by 25 ng/mL
Wnt3a, 50 ng/mL Dkk1 in combination with 1 mM BIO
(P,0.05).
(TIF)
Figure S4 The effect of LiCl on the proliferation of
iPMSCs. A, The number of iPMSCs treated with LiCl (1, 5, 10,
25 and 50 mM); B, Expression of PDX1, C-Myc and PCNA were
analysed at mRNA level treated by LiCl (1 mM, 5 mM and 10 mM)
(P,0.05).
(TIF)
Figure S5 BIO treatment resulted in nuclear accumu-
lation of b-catenin, which was not observed in control
cells. The nucleus was stained with PI.
(TIF)
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